Brillia

Manufacturer
Hadaf LLC | Santonika Uab
Effective date
2025-01-17
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
legacy-cache
Hydrated at
2026-08-01 20:42:09

Label at a glance#

ProductBrillia
Active ingredientLAPINE S-100 IMMUNE GLOBULIN
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients

Lapine S-100 immune globulin 12C, 30C, and 50C

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Lactose monohydrate, Magnesium stearate, Microcrystaline cellulose

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

Uses

  • reduce feelings of anxiety, excitability, and stress
  • reduce feelings of irritability
  • reduce feelings of irritability
  • improve concentration of attention
  • enhance clarity

DOSAGE & ADMINISTRATION SECTION

Directions

  • Children (5-18 years old) to hold 1-2 tablets in the mouth until completely dissolved. If necessary, the tablets can be taken dissolved in 1 tablespoon of drinking water
  • Should be taken 2-3 times daily for 3 months
  • Recommended to stop for 1 month (if symptoms do not return) after each 3-month regimen
  • Take no later than 2 hours before bedtime as this product has activating properties

OTC - PURPOSE SECTION

Purpose

Improve emotional regulation, hyperactivity, and attention

WARNINGS SECTION

Warnings

  • Ask a doctor or pharmacist before use if you arelactose-intolerant
  • Stop use and ask a doctor ifsymptoms persist or worsen
  • If pregnant or breast-feeding,ask a health professional before use.
  • Keep out of reach of children.If swallowed, get medical help or contact a Poison Control right away.
  • Allergic (hypersensitivity) reactions may occurin very rare cases.
  • Do not use if sensitivity to Brilliaor any of its ingredients exists.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BrilliaBrillia

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72123-00272123-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
326ba84f-ebf7-a172-e063-6394a90a2e43680778b9-52d7-562c-e053-2991aa0a72b62025-04-10WarningsExact identifier
spl set id: 680778b9-52d7-562c-e053-2991aa0a72b6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.